£71k
−11%vs May 2024Active14839659Private limited companyLondon
EYEVISION PHARMA LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
01
Summary
EYEVISION PHARMA LTD is an active private limited company (company number 14839659) incorporated on 2 May 2023, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 May 2025, showing net assets of £71k, with 3 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 11% on the prior period (£80k).
Peer position · net assets
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Key dates
- Incorporated
- 2 May 20233 yrs ago
- Next accounts due
- 28 February 2027in 129 days
- Confirmation statement due
- 16 May 2027in 206 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not disclosed
3
+200%vs May 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £71k | — | — | — | — | — | 3 |
| 31 May 2024 | £80k | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
05
Filing and accounts signals
- Net assets above zeroNet assets £71,000 at 31 May 2025
- Incorporated two to five years agoIncorporated 2 May 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
06
Ownership and control
No active person with significant control is registered.
- Sridhar Prasad
- holds 50–75% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 206 days
- Next accounts duein 129 days
- Accounts period endNet assets £71k · micro accounts
- Accounts period endNet assets £80k · micro accounts
- Incorporated
08
Similar companies in London
- A WORM COMPANY LTDLondon · inc. May 2023
- GENESYS ENTERPRISES LTDLondon · inc. May 2023
- VISION BIOCONSULTING LIMITEDLondon · inc. Apr 2023
- SEQONE GENOMICS UK LTDLondon · inc. May 2023
- MINTX.BIO LTDLondon · inc. Apr 2023
- LMN.BIO LTDLondon · inc. Apr 2023
All companies incorporated on 2 May 2023 · in May 2023.
09
Reminders for EYEVISION PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.